X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-13 | CGON | Post Leonard E | Dir | S - Sale+OE | $29.66 | -1,000 | 0 | -100% | -$29,660 | |||||
2024-12-16 | CGON | Song Hong Fang | Dir | S - Sale | $28.00 | -700,000 | 4,204,841 | -14% | -$19,600,000 | ||||||
| D | 2024-12-16 | CGON | Post Leonard E | Dir | S - Sale+OE | $28.84 | -1,000 | 0 | -100% | -$28,840 | |||||
| D | 2024-12-06 | CGON | Post Leonard E | Dir | S - Sale+OE | $34.54 | -1,000 | 0 | -100% | -$34,542 | |||||
2024-08-29 | CGON | Song Hong Fang | Dir | S - Sale | $35.36 | -650,455 | 4,904,841 | -12% | -$23,000,089 | ||||||
| A | 2024-01-29 | CGON | Decheng Capital Global Life Sciences Fund Iv, L.P. | 10% | P - Purchase | $19.00 | +400,000 | 4,958,810 | +9% | +$7,600,000 | |||||
2024-01-29 | CGON | Kasturi Vijay | Chief Medical Officer | P - Purchase | $19.00 | +1,315 | 1,315 | New | +$24,985 | ||||||
2024-01-29 | CGON | Roche Corleen M. | CFO, Secretary | P - Purchase | $19.00 | +2,000 | 2,000 | New | +$38,000 | ||||||
| D | 2024-01-29 | CGON | Song Hong Fang | Dir | P - Purchase | $19.00 | +263,157 | 5,555,296 | +5% | +$4,999,983 | |||||
| D | 2024-01-29 | CGON | Decheng Capital Global Life Sciences Fund Iv, L.P. | 10% | P - Purchase | $19.00 | +400,000 | 4,958,812 | +9% | +$7,600,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |